<html>
<head>
<title>Gandeeva Therapeutics raises $40m zoom in on biomolecules – and create new drugs in the process – TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">Gandeeva Therapeutics 筹集了 4000 万美元用于生物分子研究，并在此过程中创造新药</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2022/01/31/gandeeva-therapeutics-raises-40m-zoom-in-on-biomolecules-and-create-new-drugs-in-the-process/amp/">https://web.archive.org/web/https://techcrunch.com/2022/01/31/gandeeva-therapeutics-raises-40m-zoom-in-on-biomolecules-and-create-new-drugs-in-the-process/amp/</a></blockquote><div><div class="content">

			
	
		
		

		
<p class="amp-featured-image translated"><amp-img src="https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?w=1024" class="attachment-post-thumbnail size-post-thumbnail wp-post-image amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" alt="" srcset="https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg 2100w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=150,107 150w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=300,214 300w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=768,549 768w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=680,486 680w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=1536,1097 1536w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=2048,1463 2048w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=50,36 50w" layout="intrinsic" i-amphtml-layout="intrinsic"> <i-amphtml-sizer class="i-amphtml-sizer"> <img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/> </i-amphtml-sizer> <noscript> <img src="../Images/e50a2d83bdc91340d27aee26d95bd024.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" loading="lazy" srcset="https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg 2100w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=150,107 150w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=300,214 300w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=768,549 768w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=680,486 680w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=1536,1097 1536w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=2048,1463 2048w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?resize=50,36 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/BlueGold_BetaGalactosidase_5x7_Subramaniam-3.jpg?w=1024"/> </noscript> </amp-img></p><p class="translated"><strong>图片来源:</strong>甘迪瓦疗法</p><p class="translated">这个领域的科学家曾经开玩笑地称之为“博客写真”已经有了很大的进步。</p>
<p class="translated">低温电子显微镜以前被认为是传递生物分子的无定形图像。现在，它已经成为观察人体最小组成部分的最高保真度方法之一。这也是 Gandeeva 的一个关键支柱，Gandeeva 是一家新的生物技术公司，周一以 4000 万美元的首轮融资从隐身状态中脱颖而出。该公司计划将这种高分辨率图像与一套机器学习工具相结合，以加快药物发现的过程。</p>
<p class="translated">“我们花了大约 15 年的时间来实现我们开始时的梦想:在电子显微镜下以原子分辨率真实地观察蛋白质。联合创始人兼首席执行官斯里拉姆·苏布拉马年告诉 TechCrunch 说:“一旦我们和其他人证明这是可行的，我就清楚地知道，这是改造和革新药物发现所需的关键工具。”。</p>
<p class="translated">他继续说，甘迪瓦的论文是关于创造一个平台，这个平台实际上可以<i>从 cryo-Em 的当前进展中学习</i>。这个想法是，如果我们能够找到符合要求的药物，这些高分辨率图像可以帮助揭示以前看不到的药物结合口袋。</p>
<p class="translated">“拥有挖金子的工具是一回事，但你需要知道如何利用它——把它转化成什么产品。对我们来说，这是给病人的药物，”他说。</p>
<p class="translated">有<a href="https://web.archive.org/web/20220411000739/https://techcrunch.com/2021/06/22/a-i-drug-discovery-platform-insilico-medicine-announces-255-million-in-series-c-funding/">的</a>的的<a href="https://web.archive.org/web/20220411000739/https://techcrunch.com/2021/11/18/generate-biomedicines-raises-370m-series-b-with-a-focus-on-protein-based-drugs/">的</a>的<a href="https://web.archive.org/web/20220411000739/https://techcrunch.com/2021/10/15/nfx-backed-pepper-bio-emerges-from-stealth-with-tools-to-hone-in-on-complex-diseases/">的</a>的<a href="https://web.archive.org/web/20220411000739/https://techcrunch.com/2022/01/06/how-can-you-understand-life-if-you-dont-look-at-it-live-eikon-therapeutics-rakes-in-518m/">的</a>的<a href="https://web.archive.org/web/20220411000739/https://techcrunch.com/2021/11/04/isomorphic-labs-is-alphabets-play-in-ai-drug-discovery/">的</a>的【猛犸】的药物发现的难题。甘迪耶娃的方法，说得非常直白，就是眼见为实在寻找体内的可制毒目标时。</p>
<p class="translated">仅仅通过观察我们周围的世界，就取得了无数的科学突破。但是当谈到身体的组成部分时，如果没有特定的显微镜技术，这是不可能的。几十年来，该领域的领先技术一直是 X 射线晶体学，在这种技术中，科学家将蛋白质或分子打包成晶体，并向其发射 X 射线，近似其形状、大小和方向。</p>
<p class="translated">X 射线晶体学的问题在于结晶的过程——这个过程既费力又耗时。cryo-Em 的好处是不需要结晶。相反，分子被快速冷冻，产生 2D 片，然后用电子枪发射。这种薄片保护生物分子不受电子影响，并允许捕捉详细的图像。这种薄片还允许科学家捕捉生物分子的运动，这是用晶体包裹的结构不可能实现的过程。</p>
<p class="translated">例如，有可能获得跨度为两个 1/10 纳米的<a href="https://web.archive.org/web/20220411000739/https://www.sciencedirect.com/science/article/pii/S2590152420300027" target="_blank" rel="noopener">小结构的图像。(作为参考，一根人类头发的宽度约为</a><a href="https://web.archive.org/web/20220411000739/https://www.convertunits.com/from/hair's+breadth/to/angstrom">100 万 ngstrms</a>)。</p>
<p class="translated">有一些证据表明 cryo-EM 正处于繁荣期的中期。正如《自然》杂志 2020 年 2 月报道的那样，一些科学家预测，到 2024 年，更多的蛋白质结构将通过冷冻电镜而不是 X 射线晶体学来确定。它正在成为科学工具包中更大的一部分——尽管有时进行这项技术所需的显微镜和设备的成本高得惊人——因为分辨率已经大大提高了。</p>
<p/><div id="attachment_2264012" class="wp-caption alignnone amp-wp-e2bc858" data-amp-original-style="width: 1034px"><amp-img aria-describedby="caption-attachment-2264012" class="size-full wp-image-2264012 amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" src="https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg" alt="" srcset="https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg 2483w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=150,66 150w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=300,133 300w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=768,340 768w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=680,301 680w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=1536,679 1536w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=2048,906 2048w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=50,22 50w" layout="intrinsic" i-amphtml-layout="intrinsic"><i-amphtml-sizer class="i-amphtml-sizer"><img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/></i-amphtml-sizer><noscript><img aria-describedby="caption-attachment-2264012" loading="lazy" class="size-full wp-image-2264012" src="../Images/85e945d752ae9866125594b145475843.png" alt="" srcset="https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg 2483w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=150,66 150w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=300,133 300w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=768,340 768w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=680,301 680w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=1536,679 1536w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=2048,906 2048w, https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg?resize=50,22 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20220411000739im_/https://techcrunch.com/wp-content/uploads/2022/01/cryoEM-xray-comp-1.jpg"/></noscript></amp-img><p id="caption-attachment-2264012" class="wp-caption-text translated">左图:奥米克隆刺突蛋白的冷冻电镜图谱(<strong>图片来源:</strong>最初发表在《科学》杂志上)。<br/>右图:p97 AAA ATP 酶的 X 射线晶体学图像。<strong>图片来源:</strong>甘迪瓦疗法</p></div>
<p class="translated">与此同时，结构生物学的其他发展也对甘迪耶娃有利。首先，机器学习的进步使得准确预测蛋白质如何折叠成为可能。</p>
<p class="translated">具体来说，我们已经看到了两个能够预测蛋白质如何折叠的人工智能引擎的开发:由 Alphabet 旗下的人工智能机构 DeepMind 开发的<a href="https://web.archive.org/web/20220411000739/https://techcrunch.com/2021/07/22/deepmind-puts-the-entire-human-proteome-online-as-folded-by-alphafold/"> AlphaFold </a>，以及由华盛顿大学开发的<a href="https://web.archive.org/web/20220411000739/https://techcrunch.com/2021/07/15/researchers-match-deepminds-alphafold2-protein-folding-power-with-faster-freely-available-model/"> RoseTTAFold </a>。尽管过去需要几个小时的实验室工作来确定蛋白质结构，RoseTTAFold 声称能够在普通游戏电脑上在 10 分钟内预测出该结构。</p>
<p class="translated">苏布拉马年<a href="https://web.archive.org/web/20220411000739/https://www.nature.com/articles/s41592-021-01361-7" target="_blank" rel="noopener">认为</a>这些工具提供了对蛋白质结构和功能前所未有的深入了解，但仍有空白需要填补(例如，人工智能预测的一些元素比其他元素的可信度低)。他指出，Cryo-EM 使科学家能够放大蛋白质的特定区域，或者捕捉许多不同构象状态下的蛋白质图像(想想摆动)，也许可以填补这些空白。</p>
<p class="translated">“我们在人工智能领域发生了全新的革命，我认为每个人都在想:这一切意味着什么？人工智能和 cryo-EM 的结合，一直是 Gandeeva 的论文，是真正的入场券，因为它不仅仅是单独的实验或预测，”他说。</p>

<p class="translated">“你可以(利用)这些基于人工智能的对结构生物学和相互作用的理解，并将其与以最高速度和正确吞吐量进行的精确成像相结合。”</p>
<p class="translated">到目前为止，Gandeeva 的目标是证明 cryo-EM 实际上可以在没有政府或大学赞助的情况下快速简便地在 T2 实施。这很重要，因为苏布拉马年在这个领域的大部分工作都是在这样的环境中完成的。</p>
<p class="translated">苏布拉马年职业生涯的大部分时间是在国立卫生研究院度过的，当时他是国家癌症研究所生物物理部门的负责人。从那里，他继续建立了国家低温冷冻设备中心<span class="s1"><a href="https://web.archive.org/web/20220411000739/https://www.cancer.gov/research/resources/cryoem" target="_blank" rel="noopener"><span class="s2">，这是一个政府运营的实验室。在美国国家卫生研究院，他希望在 Gandeeva 基于 cryo-EM 的药物发现平台上取得进展，并意识到仅开发实验室就要花费数十亿美元。</span>T11】</a></span></p>
<p class="translated">他说，当时“风投对那种方式不感兴趣”。但是不列颠哥伦比亚大学做到了。他离开了国家卫生研究院，成为该大学癌症药物设计的主席。</p>
<p class="translated">“在过去的几年里，我在这里建立了这个实验室，主要是为了表明我可以重复我们在 NIH 所做的事情。所以在 UBC，我能够创造一个原型，这真的说服了投资者，这可以快速完成，”他说。</p>
<p class="translated">他的概念证明来自于《科学》杂志上发表的奥米克隆变体刺突蛋白的快速冷冻电镜图像。</p>
<p class="translated">不过，最终，Gandeeva 并不只是希望包装 cryo-EM 来拍摄漂亮的生物照片——它是一个研究平台，旨在缩短创造新药所需的时间。</p>
<p class="translated">“我们确实认为我们可以节省很多时间，仅仅是因为能够准确地观察药物结合的位置，以及它靶向的蛋白质表面。这种信息非常强大，因为它能阻止你走死胡同，”苏布拉马年说。</p>
<p class="translated">该公司将不得不证明它能够以工业速度和规模执行这项技术，并收集在其他地方找不到的信息。Gandeeva 在温哥华外的一个设施上有一个六年的租约，苏布拉马年计划在那里建立他的平台的功能。</p>
<p class="translated">在内部，我们的目标是推进一些项目，以证明他们能够识别潜在的药物靶点。苏布拉马年说，如果他不得不猜测，他可能会开始将 Gandeeva 的平台应用于肿瘤学——但这不是一成不变的。</p>
<p class="translated">本轮由 Lux Capital 领投，拜耳跃进。该轮投资包括来自 appearly Ventures、Amgen Ventures、Amplitude Ventures 和 Air Street Capital 的参与。该公司迄今已筹集了 4000 万美元。</p>


		

			
	
		

			<amp-pixel src="https://web.archive.org/web/20220411000739im_/https://ampmetrics.techcrunch.com/pixel.gif" placeholder="" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
		<amp-analytics data-credentials="include" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed">
		
	</amp-analytics>
		<amp-pixel src="https://web.archive.org/web/20220411000739im_/https://pixel.wp.com/g.gif?v=ext&amp;j=1%3A10.8&amp;blog=136296444&amp;post=2262528&amp;tz=-7&amp;srv=techcrunch.com&amp;host=techcrunch.com&amp;rand=RANDOM&amp;ref=DOCUMENT_REFERRER" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
	<amp-analytics id="tc_googleanalytics" type="googleanalytics" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_comscore" type="comscore" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>	</div>

</div>    
</body>
</html>